ArticlePeerJ2024

Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma.

Kun Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.